FDA Inspection 1241100 — Pfizer Clinical Research Unit, Hopital Erasme
The FDA completed an inspection of Pfizer Clinical Research Unit, Hopital Erasme on May 30, 2024 in Anderlecht. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 30, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Anderlecht (Belgium)
Additional Details
Clinical BA/BE